Technical Analysis for CKPT - Checkpoint Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 3.82 -2.30% -0.09
CKPT closed down 2.3 percent on Wednesday, January 17, 2018, on 62 percent of normal volume.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical CKPT trend table...

Date Alert Name Type % Chg
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 17 Inside Day Range Contraction 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.30%
Jan 16 Wide Bands Range Expansion -2.30%
Jan 12 Wide Bands Range Expansion 3.24%
Jan 11 MACD Bullish Signal Line Cross Bullish -4.02%
Jan 11 Stochastic Buy Signal Bullish -4.02%
Jan 11 Wide Bands Range Expansion -4.02%
Jan 10 Wide Bands Range Expansion 16.46%

Older signals for CKPT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Checkpoint Therapeutics, Inc. is an immuno-oncology biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. The Company is engaged in developing a portfolio of human immuno-oncology targeted antibodies. The portfolio of antibodies that it licensed includes antibodies targeting programmed death-ligand 1 (PD-L1), glucocorticoid-induced Tumor necrosis factor receptor (TNFR) related protein (GITR) and carbonic anhydrase IX (CAIX). It focuses on developing the immuno-oncology and checkpoint inhibitor antibodies. It is developing three oral, small molecules, targeted anti-cancer agents, consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Its pipeline of products includes CK-101 and CK-103.
Is CKPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.5
52 Week Low 3.2
Average Volume 59,917
200-Day Moving Average 0.0
50-Day Moving Average 4.276
20-Day Moving Average 3.6603
10-Day Moving Average 3.5895
Average True Range 0.4982
ADX 19.21
+DI 23.32
-DI 12.73
Chandelier Exit (Long, 3 ATRs ) 3.8054
Chandelier Exit (Short, 3 ATRs ) 4.6946
Upper Bollinger Band 4.1347
Lower Bollinger Band 3.1859
Percent B (%b) 0.67
BandWidth 25.921373
MACD Line -0.1948
MACD Signal Line -0.2755
MACD Histogram 0.0807
Fundamentals Value
Market Cap 96.91 Million
Num Shares 25.4 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.47
Price-to-Sales 75.20
Price-to-Book 6.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.20
Resistance 3 (R3) 4.22 4.13 4.13
Resistance 2 (R2) 4.13 4.03 4.11 4.11
Resistance 1 (R1) 3.97 3.97 3.93 3.95 4.09
Pivot Point 3.88 3.88 3.85 3.86 3.88
Support 1 (S1) 3.72 3.78 3.68 3.70 3.55
Support 2 (S2) 3.63 3.72 3.61 3.53
Support 3 (S3) 3.47 3.63 3.51
Support 4 (S4) 3.45